These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35901275)

  • 1. Contractility and Calcium Transient Maturation in the Human iPSC-Derived Cardiac Microfibers.
    Strimaityte D; Tu C; Yanez A; Itzhaki I; Wu H; Wu JC; Yang H
    ACS Appl Mater Interfaces; 2022 Aug; 14(31):35376-35388. PubMed ID: 35901275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SarcTrack.
    Toepfer CN; Sharma A; Cicconet M; Garfinkel AC; Mücke M; Neyazi M; Willcox JAL; Agarwal R; Schmid M; Rao J; Ewoldt J; Pourquié O; Chopra A; Chen CS; Seidman JG; Seidman CE
    Circ Res; 2019 Apr; 124(8):1172-1183. PubMed ID: 30700234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    Physiol Rep; 2021 Nov; 9(21):e15085. PubMed ID: 34729935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractility assessment using aligned human iPSC-derived cardiomyocytes.
    Satsuka A; Ribeiro AJS; Kawagishi H; Yanagida S; Hirata N; Yoshinaga T; Kurokawa J; Sugiyama A; Strauss DG; Kanda Y
    J Pharmacol Toxicol Methods; 2024; 128():107530. PubMed ID: 38917571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
    Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speckle-Tracking Strain Analysis for Mapping Spatiotemporal Contractility of Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes.
    Izadifar M; Berecz T; Li B; Tang JKKY; Foldes G; Apati A; Nagy A
    Curr Protoc; 2023 Sep; 3(9):e889. PubMed ID: 37747346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human iPSC-engineered cardiac tissue platform faithfully models important cardiac physiology.
    de Lange WJ; Farrell ET; Kreitzer CR; Jacobs DR; Lang D; Glukhov AV; Ralphe JC
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1670-H1686. PubMed ID: 33606581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy.
    Knight WE; Cao Y; Lin YH; Chi C; Bai B; Sparagna GC; Zhao Y; Du Y; Londono P; Reisz JA; Brown BC; Taylor MRG; Ambardekar AV; Cleveland JC; McKinsey TA; Jeong MY; Walker LA; Woulfe KC; D'Alessandro A; Chatfield KC; Xu H; Bristow MR; Buttrick PM; Song K
    Stem Cell Reports; 2021 Mar; 16(3):519-533. PubMed ID: 33636116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
    Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
    J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors.
    Wijnker PJM; Dinani R; van der Laan NC; Algül S; Knollmann BC; Verkerk AO; Remme CA; Zuurbier CJ; Kuster DWD; van der Velden J
    Cardiovasc Res; 2024 Mar; 120(3):301-317. PubMed ID: 38240646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the functional maturity of hiPSC-derived cardiomyocytes to assess inotropic compounds.
    Zhang X; Aggarwal P; Broeckel U; Abassi YA
    J Pharmacol Toxicol Methods; 2023; 123():107282. PubMed ID: 37419294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells.
    Yang X; Rodriguez M; Pabon L; Fischer KA; Reinecke H; Regnier M; Sniadecki NJ; Ruohola-Baker H; Murry CE
    J Mol Cell Cardiol; 2014 Jul; 72():296-304. PubMed ID: 24735830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
    Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
    Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes.
    Ribeiro AJS; Schwab O; Mandegar MA; Ang YS; Conklin BR; Srivastava D; Pruitt BL
    Circ Res; 2017 May; 120(10):1572-1583. PubMed ID: 28400398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.
    Lundy SD; Zhu WZ; Regnier M; Laflamme MA
    Stem Cells Dev; 2013 Jul; 22(14):1991-2002. PubMed ID: 23461462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Cheng YC; Hsieh ML; Lin CJ; Chang CMC; Huang CY; Puntney R; Wu Moy A; Ting CY; Herr Chan DZ; Nicholson MW; Lin PJ; Chen HC; Kim GC; Zhang J; Coonen J; Basu P; Simmons HA; Liu YW; Hacker TA; Kamp TJ; Hsieh PCH
    Circulation; 2023 Oct; 148(18):1395-1409. PubMed ID: 37732466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes.
    Zhang X; Ye L; Xu H; Zhou Q; Tan B; Yi Q; Yan L; Xie M; Zhang Y; Tian J; Zhu J
    Stem Cell Res Ther; 2021 Mar; 12(1):208. PubMed ID: 33762018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.